{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:11:26Z","timestamp":1790536286842,"version":"4.1.0"},"reference-count":238,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001849","name":"Defence Research and Development Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.colsurfb.2021.112303","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T03:41:02Z","timestamp":1639971662000},"page":"112303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics"],"prefix":"10.1016","volume":"211","author":[{"given":"Sheetal","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panchali","family":"Barman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhi","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Preet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avneet","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2021.112303_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/pathogens9070519","article-title":"Coronavirus disease pandemic (COVID-19): challenges and a global perspective","volume":"9","author":"Malik","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.colsurfb.2021.112303_bib2","unstructured":"Coronavirus disease (COVID-19) pandemic."},{"key":"10.1016\/j.colsurfb.2021.112303_bib3","doi-asserted-by":"crossref","first-page":"10725","DOI":"10.1590\/1414-431x202010725","article-title":"Immunity, virus evolution, and effectiveness of SARS-CoV-2 vaccines","volume":"54","author":"Beliz\u00e1rio","year":"2021","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jiph.2021.02.001","article-title":"Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy","volume":"14","author":"Chedid","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.colsurfb.2021.112303_bib5","first-page":"1","article-title":"Community use of antibiotics during the COVID-19 lockdown","author":"Gagliotti","year":"2020","journal-title":"Infect. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"lancet"},{"key":"10.1016\/j.colsurfb.2021.112303_bib7","doi-asserted-by":"crossref","first-page":"n2845","DOI":"10.1136\/bmj.n2845","article-title":"Covid-19: antimicrobial misuse in Americas sees drug resistant infections surge, says WHO","volume":"375","author":"Taylor","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.colsurfb.2021.112303_bib8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/mdr.2020.0489","article-title":"Multidrug-resistant infections and outcome of critically Ill patients with coronavirus disease 2019: a single center experience","volume":"27","author":"Karruli","year":"2021","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.colsurfb.2021.112303_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00812-20","article-title":"Pandemic COVID-19 joins history\u2019s pandemic legion","volume":"11","author":"Morens","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.colsurfb.2021.112303_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.aogh.2015.08.014","article-title":"Treatment and prevention of pandemic H1N1 influenza","volume":"81","author":"Rewar","year":"2015","journal-title":"Ann. Glob. Health"},{"key":"10.1016\/j.colsurfb.2021.112303_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)00156-2","article-title":"Cost of protection against pandemics is small","volume":"387","author":"Maurice","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2021.112303_bib12","first-page":"1","article-title":"The pandemic and its impacts. Health","volume":"9","author":"Qiu","year":"2017","journal-title":"Cult. Soc."},{"key":"10.1016\/j.colsurfb.2021.112303_bib13","unstructured":"Comparative analysis of national pandemic influenza preparedness plans, World Health Organization, 2011."},{"key":"10.1016\/j.colsurfb.2021.112303_bib14","series-title":"Virulence Mechanisms of Bacterial Pathogens","first-page":"481","article-title":"Mechanisms of antibiotic resistance","author":"Munita","year":"2016"},{"key":"10.1016\/j.colsurfb.2021.112303_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/joacp.JOACP_349_15","article-title":"Action and resistance mechanisms of antibiotics: a guide for clinicians","volume":"33","author":"Kapoor","year":"2017","journal-title":"J. Anaesthesiol., Clin. Pharmacol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-017-0208-x","article-title":"The threat of antimicrobial resistance in developing countries: causes and control strategies","volume":"6","author":"Ayukekbong","year":"2017","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.colsurfb.2021.112303_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051034","article-title":"Antibiotic resistance and persistence\u2014implications for human health and treatment perspectives","volume":"21","author":"Huemer","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.colsurfb.2021.112303_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/pharmaceutics8020018","article-title":"Current trends in development of liposomes for targeting bacterial biofilms","volume":"8","author":"Rukavina","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2021.112303_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820936161","article-title":"Nanoparticle-based drug delivery system: a patient-friendly chemotherapy for oncology","volume":"18","author":"Yan","year":"2020","journal-title":"Dose-Response"},{"key":"10.1016\/j.colsurfb.2021.112303_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.tips.2020.02.001","article-title":"Combining allosteric and orthosteric drugs to overcome drug resistance","volume":"41","author":"Ni","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.24272\/j.issn.2095-8137.2019.062","article-title":"Antimicrobial peptides: new hope in the war against multidrug resistance","volume":"40","author":"Mwangi","year":"2019","journal-title":"Zool. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-66230-3","article-title":"Green synthesis of peptide functionalized reduced graphene oxide (rGO) nano bioconjugate with enhanced antibacterial activity","volume":"10","author":"Joshi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2021.112303_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2021.112303_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13762-020-03050-y","article-title":"Synthesis and characterization of graphene oxide-bovine serum albumin conjugate membrane for adsorptive removal of Cobalt (II) from water","volume":"18","author":"Joshi","year":"2021","journal-title":"Int. J. Environ. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib25","unstructured":"20th and 21st century\u2019s major pandemics, Atlas Magazine, Groupe Atlas, 2020."},{"key":"10.1016\/j.colsurfb.2021.112303_bib26","series-title":"20 of the Worst Epidemics and Pandemics in History","author":"Jarus","year":"2020"},{"key":"10.1016\/j.colsurfb.2021.112303_bib27","unstructured":"H.C. Editors, Cholera, A&E Television Networks, HISTORY, 2017."},{"key":"10.1016\/j.colsurfb.2021.112303_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/01.PDR.0000129184.87042.FC","article-title":"Sars: the first pandemic of the 21 st century","volume":"56","author":"Cherry","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.11622\/smedj.2015105","article-title":"Alexander Fleming (1881\u20131955): discoverer of penicillin","volume":"56","author":"Tan","year":"2015","journal-title":"Singap. Med. J."},{"key":"10.1016\/j.colsurfb.2021.112303_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/molecules23040795","article-title":"Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications","volume":"23","author":"Manyi-Loh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2021.112303_bib31","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial resistance: implications and costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.colsurfb.2021.112303_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227139","article-title":"Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: systematic review and meta-analysis","volume":"15","author":"Serra-Burriel","year":"2020","journal-title":"PLOS ONE"},{"issue":"2014 (","key":"10.1016\/j.colsurfb.2021.112303_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/541340","article-title":"Multidrug resistance: an emerging crisis","volume":"2014","author":"Tanwar","year":"2014","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib34","series-title":"Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education","author":"M\u00e9ndez-Vilas","year":"2013"},{"key":"10.1016\/j.colsurfb.2021.112303_bib35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.5604\/17322693.1103268","article-title":"Proteins in cancer multidrug resistance","volume":"68","author":"Pop\u0119da","year":"2014","journal-title":"Post. Hig. Med. Do\u015bw."},{"key":"10.1016\/j.colsurfb.2021.112303_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib37","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"28","author":"Levin","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib38","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.colsurfb.2021.112303_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib40","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1128\/AAC.00573-16","article-title":"First description of mcr-1-mediated colistin resistance in human infections caused by Escherichia coli in Latin America","volume":"60","author":"Rapoport","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/dky435","article-title":"Wide dissemination of colistin-resistant Escherichia coli with the mobile resistance gene mcr in healthy residents in Vietnam","volume":"74","author":"Yamamoto","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib42","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMoa025025","article-title":"Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene","volume":"348","author":"Chang","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.colsurfb.2021.112303_bib43","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the Enterococcus: beyond vancomycin resistance","volume":"10","author":"Arias","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib45","first-page":"214","article-title":"Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit","volume":"17","author":"Gurung","year":"2013","journal-title":"Indian J. Crit. Care Med.\u00a0Peer Rev. Off. Publ. Indian Soc. Crit. Care Med."},{"key":"10.1016\/j.colsurfb.2021.112303_bib46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1473-3099(17)30274-8","article-title":"Staphylococcus aureus in critical care","volume":"17","author":"Dotel","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3889\/oamjms.2019.009","article-title":"Vancomycin MIC distribution among methicillin-resistant Staphylococcus aureus. Is reduced vancomycin susceptibility related to MIC creep?","volume":"7","author":"Othman","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"key":"10.1016\/j.colsurfb.2021.112303_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.colsurfb.2021.112303_bib50","article-title":"The influence of the gut microbiota on the bioavailability of oral drugs","author":"Zhang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2021.112303_bib51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","article-title":"Challenges and recent progress in oral drug delivery systems for biopharmaceuticals","volume":"11","author":"Homayun","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2021.112303_bib52","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1086\/344658","article-title":"Antifungal drug resistance","volume":"36","author":"Loeffler","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP\u2013dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2021.112303_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fphar.2013.00028","article-title":"Mechanisms and insights into drug resistance in cancer","volume":"4","author":"Zahreddine","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.colsurfb.2021.112303_bib55","first-page":"909","article-title":"Primary and acquired drug resistance in childhood tuberculosis","volume":"12","author":"Khalilzadeh","year":"2006","journal-title":"EMHJ East. Mediterr. Health J."},{"key":"10.1016\/j.colsurfb.2021.112303_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-019-1199-3","article-title":"Primary drug resistance of Mycobacterium tuberculosis in Shandong, China, 2004\u20132018","volume":"20","author":"Song","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib57","doi-asserted-by":"crossref","first-page":"378","DOI":"10.34297\/AJBSR.2020.07.001181","article-title":"Mechanism of drug resistance in mycobacterium tuberculosis","volume":"7","author":"Abraham","year":"2020","journal-title":"Am. J. Biomed. Sci. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.colsurfb.2021.112303_bib59","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.colsurfb.2021.112303_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep37853","article-title":"Optimising antibiotic usage to treat bacterial infections","volume":"6","author":"Paterson","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2021.112303_bib61","article-title":"Therapeutic drug monitoring-guided high dose meropenem therapy of a multidrug resistant Acinetobacter baumannii-a case report","volume":"29","author":"Liebchen","year":"2020","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.colsurfb.2021.112303_bib62","first-page":"121","article-title":"Mechanisms of resistance to carbapenems in meropenem-resistant Acinetobacter isolates from clinical samples","volume":"25","author":"Sinha","year":"2007","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib63","article-title":"Vancomycin-resistant Staphylococcus aureus: formidable threat or silence before the storm","volume":"5","author":"Kest","year":"2019","journal-title":"J. Infect. Dis. Epidemiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib64","first-page":"269","article-title":"Focus: infectious diseases: vancomycin resistance in Staphylococcus aureus","volume":"90","author":"McGuinness","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.colsurfb.2021.112303_bib65","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/femsre\/fuz014","article-title":"Antibiotic resistance breakers: current approaches and future directions","volume":"43","author":"Laws","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.colsurfb.2021.112303_bib66","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.addr.2005.04.003","article-title":"Bacterial resistance to antibiotics: modified target sites","volume":"57","author":"Lambert","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2021.112303_bib67","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/EC.00334-13","article-title":"Using Aspergillus nidulans to identify antifungal drug resistance mutations","volume":"13","author":"He","year":"2014","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.colsurfb.2021.112303_bib68","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.03.011","article-title":"Mechanisms of antimicrobial resistance in bacteria","volume":"119","author":"Tenover","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.colsurfb.2021.112303_bib69","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.colsurfb.2021.112303_bib70","article-title":"Antibiotic resistance mechanisms in bacteria: biochemical and genetic aspects","volume":"46","author":"D\u017eidi\u0107","year":"2008","journal-title":"Food Technol. Biotechnol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.32607\/20758251-2018-10-4-33-48","article-title":"Bacterial enzymes and antibiotic resistance","volume":"10","author":"Egorov","year":"2018","journal-title":"Acta Nat."},{"key":"10.1016\/j.colsurfb.2021.112303_bib72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","article-title":"Multidrug resistance in bacteria","volume":"78","author":"Nikaido","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.colsurfb.2021.112303_bib73","first-page":"809","article-title":"Antiviral drug resistance: mechanisms and clinical implications","volume":"24","author":"Strasfeld","year":"2010","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.colsurfb.2021.112303_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00184-5","article-title":"Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance","volume":"108","author":"McFadden","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib75","series-title":"Drug Resistance in Malaria","author":"Bloland","year":"2001"},{"key":"10.1016\/j.colsurfb.2021.112303_bib76","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10989-019-09946-9","article-title":"Antimicrobial peptides (AMPs): roles, functions and mechanism of action","volume":"26","author":"Seyfi","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.colsurfb.2021.112303_bib77","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/biom8010004","article-title":"Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo","volume":"8","author":"Kumar","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.colsurfb.2021.112303_bib78","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2165\/11317030-000000000-00000","article-title":"Efflux-mediated drug resistance in bacteria","volume":"69","author":"Li","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.colsurfb.2021.112303_bib79","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1383-5769(02)00041-7","article-title":"Multidrug resistance in the protozoan parasite Entamoeba histolytica","volume":"51","author":"Orozco","year":"2002","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.colsurfb.2021.112303_bib80","first-page":"189","article-title":"Multidrug resistance in amoebiasis patients","volume":"124","author":"Bansal","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib81","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/138920111795163887","article-title":"Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy","volume":"12","author":"Wu","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib82","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.addr.2013.09.018","article-title":"Multidrug resistance: physiological principles and nanomedical solutions","volume":"65","author":"Kunjachan","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2021.112303_bib83","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41396-019-0344-9","article-title":"Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates","volume":"13","author":"Windels","year":"2019","journal-title":"ISME J."},{"key":"10.1016\/j.colsurfb.2021.112303_bib84","series-title":"Antipsychotic Medications","author":"Chokhawala","year":"2020"},{"key":"10.1016\/j.colsurfb.2021.112303_bib85","first-page":"655","article-title":"Selective COX-2 inhibitors: a review of their structure-activity relationships","volume":"10","author":"Zarghi","year":"2011","journal-title":"Iran. J. Pharm. Res. IJPR"},{"key":"10.1016\/j.colsurfb.2021.112303_bib86","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/JPER.18-0673","article-title":"Priyadharsini, In silico validation of the non\u2010antibiotic drugs acetaminophen and ibuprofen as antibacterial agents against red complex pathogens","volume":"90","author":"Vijayashree","year":"2019","journal-title":"J. Periodontol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib87","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1128\/IAI.00076-11","article-title":"Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns","volume":"79","author":"Giannoni","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.colsurfb.2021.112303_bib88","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/00016480510027529","article-title":"External otitis caused by infection with Pseudomonas aeruginosa or Candida albicans cured by use of a topical group III steroid, without any antibiotics","volume":"125","author":"Emg\u00e5rd","year":"2005","journal-title":"Acta Oto Laryngol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib89","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/antibiotics9020065","article-title":"Strategies to combat multidrug-resistant and persistent infectious diseases","volume":"9","author":"Pacios","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.colsurfb.2021.112303_bib90","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review","volume":"36","author":"Garc\u00eda","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib91","first-page":"1657","article-title":"New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine","volume":"11","author":"Werner","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.colsurfb.2021.112303_bib92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuro.2020.12.015","article-title":"Neuroprotective effects of carbenoxolone against amyloid-beta 1\u201342 oligomer-induced neuroinflammation and cognitive decline in rats","volume":"83","author":"Sharma","year":"2021","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.colsurfb.2021.112303_bib93","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuroscience.2020.02.004","article-title":"Maintenance of amyloid-beta homeostasis by carbenoxolone post A\u03b2-42 oligomer injection in rat brain","volume":"431","author":"Sharma","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.colsurfb.2021.112303_bib94","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s12640-018-9975-2","article-title":"Carbenoxolone reverses the amyloid beta 1\u201342 oligomer\u2013induced oxidative damage and anxiety-related behavior in rats","volume":"35","author":"Sharma","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib95","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuint.2017.06.011","article-title":"Inhibition of Alzheimer\u2019s amyloid-beta aggregation in-vitro by carbenoxolone: insight into mechanism of action","volume":"108","author":"Sharma","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.colsurfb.2021.112303_bib96","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0924-8579(02)00110-3","article-title":"Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus","volume":"20","author":"Ordway","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.colsurfb.2021.112303_bib97","first-page":"161","article-title":"In vitro activity of thioridazine against mycobacteria","volume":"34","author":"van Ingen","year":"2009","journal-title":"Nontubercul. Mycobact."},{"key":"10.1016\/j.colsurfb.2021.112303_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001944.pub2","article-title":"Thioridazine for schizophrenia","author":"Fenton","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.colsurfb.2021.112303_bib99","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1128\/AAC.00326-16","article-title":"New role for FDA-approved drugs in combating antibiotic-resistant bacteria","volume":"60","author":"Andersson","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fcimb.2018.00438","article-title":"Repurposing screen identifies unconventional drugs with activity against multidrug resistant Acinetobacter baumannii","volume":"8","author":"Cheng","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib101","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fcimb.2018.00316","article-title":"Antimicrobial activity of gallium compounds on ESKAPE pathogens","volume":"8","author":"Hijazi","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib102","article-title":"Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections","volume":"10","author":"Goss","year":"2018","journal-title":"Gallium Disrupts Bact. Iron Metab. Has. Ther. Eff. Mice Hum. Lung Infect., Sci. Transl. Med."},{"key":"10.1016\/j.colsurfb.2021.112303_bib103","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/bit.25963","article-title":"DNA\u2010crosslinker cisplatin eradicates bacterial persister cells","volume":"113","author":"Chowdhury","year":"2016","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.colsurfb.2021.112303_bib104","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1073\/pnas.1511751112","article-title":"Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase","volume":"112","author":"Farha","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib105","series-title":"Antineoplatic Antibiotic","author":"Britannica","year":"2017"},{"key":"10.1016\/j.colsurfb.2021.112303_bib106","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/14787210.2020.1752665","article-title":"Repurposed anti-cancer drugs: the future for anti-infective therapy?","volume":"18","author":"Quezada","year":"2020","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.colsurfb.2021.112303_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124595","article-title":"Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus","volume":"10","author":"Rajamuthiah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.colsurfb.2021.112303_bib108","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/AAC.01952-12","article-title":"New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing","volume":"57","author":"Imperi","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib109","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fcimb.2018.00348","article-title":"Synergistic activity of niclosamide in combination with colistin against colistin-susceptible and colistin-resistant Acinetobacter baumannii and Klebsiella pneumoniae","volume":"8","author":"Ayerbe-Algaba","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep33642","article-title":"Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile","volume":"6","author":"Gooyit","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2021.112303_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003549","article-title":"In-vitro activity of avermectins against Mycobacterium ulcerans","volume":"9","author":"Omansen","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib112","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00011-008-8007-8","article-title":"Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice","volume":"57","author":"Zhang","year":"2008","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib113","unstructured":"S. Campbell, K. Soman-Faulkner, Antiparasitic Drugs, 2019."},{"key":"10.1016\/j.colsurfb.2021.112303_bib114","series-title":"Antiparasitics","author":"Coppoc","year":"1996"},{"key":"10.1016\/j.colsurfb.2021.112303_bib115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3013","article-title":"Anti-virulence strategies to combat bacteria-mediated disease","volume":"9","author":"Rasko","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2021.112303_bib116","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1007\/s00253-013-5185-2","article-title":"(Z)-4-Bromo-5-(bromomethylene)-3-methylfuran-2 (5H)-one sensitizes Escherichia coli persister cells to antibiotics","volume":"97","author":"Pan","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib117","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature12790","article-title":"Activated ClpP kills persisters and eradicates a chronic biofilm infection","volume":"503","author":"Conlon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2021.112303_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004321","article-title":"Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity","volume":"10","author":"Starkey","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.colsurfb.2021.112303_bib119","series-title":"Disarming Pathogens: Benefits and Challenges of Antimicrobials that Target Bacterial Virulence Instead of Growth and Viability","author":"Totsika","year":"2017"},{"key":"10.1016\/j.colsurfb.2021.112303_bib120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature26157","article-title":"A new class of synthetic retinoid antibiotics effective against bacterial persisters","volume":"556","author":"Kim","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2021.112303_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/cr400126u","article-title":"Functions, therapeutic applications, and synthesis of retinoids and carotenoids","volume":"114","author":"Alvarez","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.colsurfb.2021.112303_bib122","series-title":"Vitamin A Toxicity","author":"Olson","year":"2021"},{"key":"10.1016\/j.colsurfb.2021.112303_bib123","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt0206-163","article-title":"Designer combination therapy for cancer","volume":"24","author":"Lane","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib124","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35073673","article-title":"HIV chemotherapy","volume":"410","author":"Richman","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2021.112303_bib125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.colsurfb.2021.112303_bib126","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5588\/ijtld.12.0083","article-title":"The chemotherapy of tuberculosis: past, present and future","author":"Mitchison","year":"2012","journal-title":"Int. J. Tuberc Lung Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib127","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00873-18","article-title":"Synergistic activity of colistin-containing combinations against colistin-resistant Enterobacteriaceae","volume":"62","author":"Brennan-Krohn","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijantimicag.2007.07.037","article-title":"The clinical development and launch of amoxicillin\/clavulanate for the treatment of a range of community-acquired infections","volume":"30","author":"Ball","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.colsurfb.2021.112303_bib129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/jac\/dkq520","article-title":"Does broad-spectrum \u03b2-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?","volume":"66","author":"Nordmann","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib130","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/AAC.01370-10","article-title":"In vitro and in vivo properties of BAL30376, a \u03b2-lactam and dual \u03b2-lactamase inhibitor combination with enhanced activity against Gram-negative bacilli that express multiple \u03b2-lactamases","volume":"55","author":"Page","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib131","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mib.2010.01.008","article-title":"Two-component signal transduction as potential drug targets in pathogenic bacteria","volume":"13","author":"Gotoh","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib132","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2165\/00003495-198223060-00003","article-title":"Fixed combination drug therapy","volume":"23","author":"Shenfield","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.colsurfb.2021.112303_bib133","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2165\/00003495-199652030-00005","article-title":"Combination antimicrobial therapy for bacterial infections","volume":"52","author":"Rybak","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.colsurfb.2021.112303_bib134","first-page":"601","article-title":"Pharmacokinetic drug-drug interaction and their implication in clinical management","volume":"18","author":"Palleria","year":"2013","journal-title":"J. Res. Med. Sci.: Off. J. Isfahan Univ. Med. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s13556-012-0002-2","article-title":"Unique risks, benefits, and challenges of developing drug-drug combination products in a pharmaceutical industrial setting","volume":"2","author":"Pourkavoos","year":"2012","journal-title":"Comb. Prod. Ther."},{"key":"10.1016\/j.colsurfb.2021.112303_bib136","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fphar.2018.00281","article-title":"Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds","volume":"9","author":"Pfalzgraff","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib137","first-page":"3919","article-title":"The antimicrobial peptides and their potential clinical applications","volume":"11","author":"Lei","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib138","series-title":"A Synthetic Peptide Possessing Antimicrobial and Anticancer Properties","article-title":"A synthetic peptide possessing antimicrobial and anticancer properties","author":"Avneet Saini","year":"2020"},{"key":"10.1016\/j.colsurfb.2021.112303_bib139","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.3390\/ijms12095971","article-title":"The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation","volume":"12","author":"Park","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-019-3989-1","article-title":"A review on peptide functionalized graphene derivatives as nanotools for biosensing","volume":"187","author":"Joshi","year":"2020","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.colsurfb.2021.112303_bib141","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/psc.2633","article-title":"Self\u2010assembling amphiphilic peptides","volume":"20","author":"Dehsorkhi","year":"2014","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib142","first-page":"41","article-title":"Hydrophilic\/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates","volume":"36","author":"Cun-Bao","year":"2015","journal-title":"Zool. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib143","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/molecules22071054","article-title":"Rational design of cyclic antimicrobial peptides based on BPC194 and BPC198","volume":"22","author":"Cirac","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2021.112303_bib144","article-title":"Antimicrobial peptides: a potential therapeutic option for surgical site infections","volume":"2","author":"Deslouches","year":"2017","journal-title":"Clin. Surg."},{"key":"10.1016\/j.colsurfb.2021.112303_bib145","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1039\/C7SC01599B","article-title":"Design, crystal structure and atomic force microscopy study of thioether ligated d, l-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa","volume":"8","author":"He","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib146","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/cbic.201800618","article-title":"Photopharmacological control of cyclic antimicrobial peptides","volume":"19","author":"Yeoh","year":"2018","journal-title":"ChemBioChem"},{"key":"10.1016\/j.colsurfb.2021.112303_bib147","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jcis.2018.08.042","article-title":"Dependence on size and shape of non-nature amino acids in the enhancement of lipopolysaccharide (LPS) neutralizing activities of antimicrobial peptides","volume":"533","author":"Chih","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib148","doi-asserted-by":"crossref","first-page":"198","DOI":"10.24272\/j.issn.2095-8137.2018.070","article-title":"Effects of C-terminal amidation and heptapeptide ring on the biological activities and advanced structure of amurin-9KY, a novel antimicrobial peptide identified from the brown frog, Rana kunyuensis","volume":"40","author":"Zhang","year":"2019","journal-title":"Zool. Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib149","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00145-20","article-title":"In vitro and in vivo antibiotic capacity of two host defense peptides","volume":"64","author":"Arenas","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib150","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/acsinfecdis.0c00016","article-title":"Combined efficacy of an antimicrobial cationic peptide polymer with conventional antibiotics to combat multidrug-resistant pathogens","volume":"6","author":"Thappeta","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib151","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1128\/AAC.02434-15","article-title":"Combination effects of antimicrobial peptides","volume":"60","author":"Yu","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib152","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nnano.2010.29","article-title":"Kinetics of antimicrobial peptide activity measured on individual bacterial cells using high-speed atomic force microscopy","volume":"5","author":"Fantner","year":"2010","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib153","doi-asserted-by":"crossref","DOI":"10.1098\/rspb.2017.2687","article-title":"Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics","volume":"285","author":"Yu","year":"2018","journal-title":"Proc. R. Soc. B: Biol. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-12364-6","article-title":"Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance","volume":"10","author":"Spohn","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2021.112303_bib155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fmicb.2020.00103","article-title":"Resistance evolution against antimicrobial peptides in Staphylococcus aureus alters pharmacodynamics beyond the mic","volume":"11","author":"El Shazely","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib156","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/fmb.13.53","article-title":"Copy number change: evolving views on gene amplification","volume":"8","author":"Elliott","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib157","doi-asserted-by":"crossref","DOI":"10.1098\/rsbl.2018.0006","article-title":"Cationic antimicrobial peptides do not change recombination frequency in Escherichia coli","volume":"14","author":"Rodr\u00edguez-Rojas","year":"2018","journal-title":"Biol. Lett."},{"key":"10.1016\/j.colsurfb.2021.112303_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004445","article-title":"Antimicrobials, stress and mutagenesis","volume":"10","author":"Rodr\u00edguez-Rojas","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.colsurfb.2021.112303_bib159","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molcel.2010.01.003","article-title":"Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis","volume":"37","author":"Kohanski","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.colsurfb.2021.112303_bib160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005546","article-title":"Cationic peptides facilitate iron-induced mutagenesis in bacteria","volume":"11","author":"Rodr\u00edguez-Rojas","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.colsurfb.2021.112303_bib161","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbamem.2015.10.024","article-title":"Hit\u2019em where it hurts: the growing and structurally diverse family of peptides that target lipid-II","volume":"1858","author":"Oppedijk","year":"2016","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib162","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1007\/s00253-016-7732-0","article-title":"Targeting bactoprenol-coupled cell envelope precursors","volume":"100","author":"Ulm","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib163","first-page":"41","article-title":"Lead molecules from natural products: insight into tubercular targets","author":"Faustino","year":"2020","journal-title":"Stud. Nat. Prod. Chem."},{"key":"10.1016\/j.colsurfb.2021.112303_bib164","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1128\/AAC.00237-15","article-title":"Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides","volume":"59","author":"Mojsoska","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib165","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/07388551.2020.1796576","article-title":"Antimicrobial peptides as therapeutic agents: opportunities and challenges","volume":"40","author":"Mahlapuu","year":"2020","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib166","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.bbamem.2015.10.018","article-title":"Molecular mechanisms of membrane targeting antibiotics","volume":"1858","author":"Epand","year":"2016","journal-title":"Biochim. Biophys. Acta\u00a0BBA Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib167","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.3389\/fmicb.2019.02866","article-title":"Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions","volume":"10","author":"Raheem","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583500000123","article-title":"Electrically gated ionic channels in lipid bilayers","volume":"10","author":"Ehrenstein","year":"1977","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.colsurfb.2021.112303_bib169","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0005-2736(99)00208-4","article-title":"The lantibiotic nisin, a special case or not?","volume":"1462","author":"Breukink","year":"1999","journal-title":"Biochim. Biophys. Acta\u00a0BBA Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria","author":"Brogden","year":"2005","journal-title":"Nat. Rev. microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib171","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1021\/bi00154a022","article-title":"Interaction of D-amino acid incorporated analogs of pardaxin with membranes","volume":"31","author":"Pouny","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.colsurfb.2021.112303_bib172","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/cb1001558","article-title":"Describing the mechanism of antimicrobial peptide action with the interfacial activity model","volume":"5","author":"Wimley","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib173","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0005-2736(01)00429-1","article-title":"General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides","volume":"1558","author":"Dathe","year":"2002","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib174","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.bbamem.2008.06.007","article-title":"Toroidal pores formed by antimicrobial peptides show significant disorder","volume":"1778","author":"Sengupta","year":"2008","journal-title":"Biochim. Biophys. Acta\u00a0BBA Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bpj.2008.10.012","article-title":"Effect of membrane composition on antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs","volume":"96","author":"Cheng","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.colsurfb.2021.112303_bib176","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1568026615666150703121700","article-title":"Antimicrobial peptide structure and mechanism of action: a focus on the role of membrane structure","volume":"16","author":"Lee","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.colsurfb.2021.112303_bib177","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/bip.10260","article-title":"Mode of action of membrane active antimicrobial peptides","volume":"66","author":"Shai","year":"2002","journal-title":"Biopolymers"},{"key":"10.1016\/j.colsurfb.2021.112303_bib178","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.colsurfb.2021.112303_bib179","doi-asserted-by":"crossref","first-page":"15739","DOI":"10.1039\/c2cp43099a","article-title":"The antimicrobial peptide aurein 1.2 disrupts model membranes via the carpet mechanism","volume":"14","author":"Fernandez","year":"2012","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.colsurfb.2021.112303_bib180","doi-asserted-by":"crossref","first-page":"15765","DOI":"10.1021\/bi000714m","article-title":"Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles","volume":"39","author":"Rozek","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.colsurfb.2021.112303_bib181","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0005-2736(99)00199-6","article-title":"Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity","volume":"1462","author":"Sitaram","year":"1999","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib182","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/ph9030059","article-title":"Antimicrobial peptides targeting gram-positive bacteria","volume":"9","author":"Malanovic","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.colsurfb.2021.112303_bib183","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1016\/j.bbamem.2015.04.014","article-title":"Structural variations of the cell wall precursor lipid II in Gram-positive bacteria\u2014impact on binding and efficacy of antimicrobial peptides","volume":"1848","author":"M\u00fcnch","year":"2015","journal-title":"Biochim. Biophys. Acta\u00a0BBA Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib184","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7164\/antibiotics.45.832","article-title":"Mersacidin, a new antibiotic from bacillus fermentation, isolation, purification and chemical characterization","volume":"45","author":"Chatterjee","year":"1992","journal-title":"J. Antibiot."},{"key":"10.1016\/j.colsurfb.2021.112303_bib185","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.febslet.2010.03.004","article-title":"Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II","volume":"584","author":"de Leeuw","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.colsurfb.2021.112303_bib186","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.7164\/antibiotics.43.1403","article-title":"Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2 structural revision of duramycin and cinnamycin","volume":"43","author":"Fredenhagen","year":"1990","journal-title":"J. Antibiot."},{"key":"10.1016\/j.colsurfb.2021.112303_bib187","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/JB.183.6.2137-2140.2001","article-title":"Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase","volume":"183","author":"del Castillo","year":"2001","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib188","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1046\/j.1432-1033.2002.03119.x","article-title":"Identification of crucial residues for the antibacterial activity of the proline\u2010rich peptide, pyrrhocoricin","volume":"269","author":"Kragol","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.colsurfb.2021.112303_bib189","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1021\/bi002656a","article-title":"The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding","volume":"40","author":"Kragol","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.colsurfb.2021.112303_bib190","doi-asserted-by":"crossref","first-page":"14150","DOI":"10.1021\/bi0012843","article-title":"Interaction between heat shock proteins and antimicrobial peptides","volume":"39","author":"Otvos","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.colsurfb.2021.112303_bib191","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/iai.61.7.2978-2984.1993","article-title":"Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine","volume":"61","author":"Boman","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.colsurfb.2021.112303_bib192","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.bbamem.2008.10.025","article-title":"Buforins: histone H2A-derived antimicrobial peptides from toad stomach","volume":"1788","author":"Cho","year":"2009","journal-title":"Biochim. Et. Biophys. Acta\u00a0BBA Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib193","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1093\/nar\/gki725","article-title":"Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA","volume":"33","author":"Hsu","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.colsurfb.2021.112303_bib194","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/bbrc.1998.8159","article-title":"Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions","volume":"244","author":"Park","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.colsurfb.2021.112303_bib195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6968.1998.tb12896.x","article-title":"Mechanism of antimicrobial action of indolicidin","volume":"160","author":"Subbalakshmi","year":"1998","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.colsurfb.2021.112303_bib196","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1086\/338514","article-title":"Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins, The","volume":"185","author":"Xiong","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2021.112303_bib197","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrmicro2745","article-title":"Modulating immunity as a therapy for bacterial infections","volume":"10","author":"Hancock","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib198","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nchembio.1393","article-title":"Immune modulation by multifaceted cationic host defense (antimicrobial) peptides","volume":"9","author":"Hilchie","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib199","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2174\/138161212799277617","article-title":"Therapeutic potential of host defense peptides in antibiotic-resistant infections","volume":"18","author":"Afacan","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.colsurfb.2021.112303_bib200","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3389\/fimmu.2020.02077","article-title":"The dual role of antimicrobial peptides in autoimmunity","volume":"11","author":"Liang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib201","doi-asserted-by":"crossref","first-page":"18631","DOI":"10.1073\/pnas.0702130104","article-title":"Human \u03b2-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2","volume":"104","author":"Funderburg","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib202","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4049\/jimmunol.1000597","article-title":"CCL20 and \u03b2-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions","volume":"186","author":"Ghannam","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib203","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clim.2009.01.012","article-title":"Impact of \u03b1-defensins1\u20133 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects","volume":"131","author":"Rodr\u00edguez-Garc\u00eda","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib204","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule\u2013and epithelial cell\u2013derived cathelicidin, utilizes formyl peptide receptor\u2013like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells","volume":"192","author":"Yang","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.colsurfb.2021.112303_bib205","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/14787210.2021.1912593","article-title":"Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2","volume":"19","author":"Mousavi Maleki","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.colsurfb.2021.112303_bib206","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.582779","article-title":"Antimicrobial peptides: classification, design, application and research progress in multiple fields","volume":"11","author":"Huan","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib207","article-title":"Oral antimicrobial peptides and new therapeutic strategies for plaque-mediated diseases","volume":"21","author":"Izadi","year":"2020","journal-title":"Gene Rep."},{"key":"10.1016\/j.colsurfb.2021.112303_bib208","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.anaerobe.2017.05.016","article-title":"A novel antimicrobial peptide against dental-caries-associated bacteria","volume":"47","author":"Chen","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.colsurfb.2021.112303_bib209","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.actbio.2019.12.025","article-title":"Topical antimicrobial peptide formulations for wound healing: current developments and future prospects","volume":"103","author":"Thapa","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2021.112303_bib210","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijantimicag.2014.12.015","article-title":"Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds","volume":"45","author":"Bj\u00f6rn","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.colsurfb.2021.112303_bib211","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/AAC.00095-14","article-title":"Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2021.112303_bib212","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00018-014-1694-0","article-title":"Esculentin-1a (1-21) NH 2: a frog skin-derived peptide for microbial keratitis","volume":"72","author":"Kolar","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib213","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1167\/iovs.17-22243","article-title":"Designed host defense peptides for the treatment of bacterial keratitis","volume":"58","author":"Clemens","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib214","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41522-018-0053-6","article-title":"Fighting biofilms with lantibiotics and other groups of bacteriocins","volume":"4","author":"Mathur","year":"2018","journal-title":"npj Biofilms Micro"},{"key":"10.1016\/j.colsurfb.2021.112303_bib215","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.3390\/app11146595","article-title":"The intestinal biofilm of pseudomonas aeruginosa and staphylococcus aureus is inhibited by antimicrobial peptides HBD-2 and HBD-3","volume":"11","author":"Fusco","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105056","article-title":"Synergistic effect and antibiofilm activity of an antimicrobial peptide with traditional antibiotics against multi-drug resistant bacteria","volume":"158","author":"Duan","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.colsurfb.2021.112303_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113433","article-title":"An optimized analog of antimicrobial peptide Jelleine-1 shows enhanced antimicrobial activity against multidrug resistant P. aeruginosa and negligible toxicity in vitro and in vivo","volume":"219","author":"Zhou","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2021.112303_bib218","article-title":"Anti-biofilm and anti-inflammatory effects of Lycosin-II isolated from spiders against multi-drug resistant bacteria","volume":"2022","author":"Oh","year":"1864","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib219","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/pharmaceutics13111800","article-title":"Development of novel peptides for the antimicrobial combination therapy against carbapenem-resistant acinetobacter baumannii infection","volume":"13","author":"Choi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2021.112303_bib220","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/antibiotics10060712","article-title":"The design of alapropoginine, a novel conjugated ultrashort antimicrobial peptide with potent synergistic antimicrobial activity in combination with conventional antibiotics","volume":"10","author":"Salama","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.colsurfb.2021.112303_bib221","article-title":"Thrombocidin-1-derived antimicrobial peptide TC19 combats superficial multi-drug resistant bacterial wound infections","volume":"1862","author":"Riool","year":"2020","journal-title":"Biochim. Et. Biophys. Acta BBA Biomembr."},{"key":"10.1016\/j.colsurfb.2021.112303_bib222","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1007\/s10989-021-10243-7","article-title":"Linear and branched forms of short antimicrobial peptide-IRK Inhibit growth of multi drug resistant staphylococcus aureus isolates from mastitic cow milk","volume":"27","author":"Gogoi","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.colsurfb.2021.112303_bib223","article-title":"Antibacterial efficacy of in\u2010house designed cell\u2010penetrating peptide against multi\u2010drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium","author":"Nishanth","year":"2021","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib224","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ifset.2018.06.008","article-title":"Nisin and other antimicrobial peptides: production, mechanisms of action, and application in active food packaging","volume":"48","author":"Santos","year":"2018","journal-title":"Innov. Food Sci. Emerg. Technol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib225","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ifset.2015.12.013","article-title":"Integration of nisin into nanoparticles for application in foods","volume":"34","author":"Khan","year":"2016","journal-title":"Innov. Food Sci. Emerg. Technol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib226","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s13197-016-2318-5","article-title":"Antimicrobial peptides as natural bio-preservative to enhance the shelf-life of food","volume":"53","author":"Rai","year":"2016","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib227","doi-asserted-by":"crossref","DOI":"10.1111\/jfpp.13370","article-title":"Antimicrobial packaging based on \u025b\u2010polylysine bioactive film for the control of mycotoxigenic fungi in vitro and in bread","volume":"42","author":"Luz","year":"2018","journal-title":"J. Food Process. Preserv."},{"key":"10.1016\/j.colsurfb.2021.112303_bib228","first-page":"6714","article-title":"Antimicrobial activity of nisinproduced by lactocococcuslactis subsp. lactis against multi drug-resistant oral pathogens","volume":"7","author":"Sharma","year":"2021","journal-title":"Eur. J. Mol. Clin. Med."},{"key":"10.1016\/j.colsurfb.2021.112303_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104050","article-title":"Combinations of early generation antibiotics and antimicrobial peptides are effective against a broad spectrum of bacterial biothreat agents","volume":"142","author":"Cote","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.colsurfb.2021.112303_bib230","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/med.21542","article-title":"Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era","volume":"39","author":"Wang","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.colsurfb.2021.112303_bib231","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3382\/ps.2009-00461","article-title":"Swine intestine antimicrobial peptides inhibit infectious bronchitis virus infectivity in chick embryos","volume":"89","author":"Sun","year":"2010","journal-title":"Poult. Sci."},{"key":"10.1016\/j.colsurfb.2021.112303_bib232","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.fsi.2019.11.019","article-title":"Exploring small cationic peptides of different origin as potential antimicrobial agents in aquaculture","volume":"98","author":"Leon","year":"2020","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib233","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.fsi.2017.06.006","article-title":"Isolation and characterization of antimicrobial peptides derived from Bacillus subtilis E20-fermented soybean meal and its use for preventing Vibrio infection in shrimp aquaculture","volume":"67","author":"Cheng","year":"2017","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib234","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1007\/s00253-018-9420-8","article-title":"Bacteriocins: perspective for the development of novel anticancer drugs","volume":"102","author":"Baindara","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib235","series-title":"Antimicrobials from a Feline Commensal Bacterium Inhibit Skin Infection by Drug-resistant S. Pseudintermedius","author":"O\u2019Neill","year":"2021"},{"key":"10.1016\/j.colsurfb.2021.112303_bib236","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.postharvbio.2018.11.025","article-title":"Control of sour rot in citrus fruit by three insect antimicrobial peptides","volume":"149","author":"Liu","year":"2019","journal-title":"Postharvest Biol. Technol."},{"key":"10.1016\/j.colsurfb.2021.112303_bib237","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2174\/1381612824666180213130318","article-title":"The modification and design of antimicrobial peptide","volume":"24","author":"Gao","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.colsurfb.2021.112303_bib238","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cis.2017.01.005","article-title":"Delivery systems for antimicrobial peptides","volume":"242","author":"Nordstr\u00f6m","year":"2017","journal-title":"Adv. Colloid Interface Sci."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776521007499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776521007499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:05:38Z","timestamp":1760526338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776521007499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":238,"alternative-id":["S0927776521007499"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112303","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112303"}}